CMV disease in AIDS patients:: Incidence of CMV disease and relation to survival in a population-based study from Oslo

被引:20
作者
Brantsæter, AB
Liestol, K
Goplen, AK
Dunlop, O
Bruun, JN
机构
[1] Ullevaal Univ Hosp, Dept Infect Dis, Oslo, Norway
[2] Univ Oslo, Dept Informat, N-0316 Oslo, Norway
[3] Ullevaal Univ Hosp, Dept Pathol, Oslo, Norway
关键词
D O I
10.1080/00365540110076976
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
CMV disease is an important cause of morbidity and mortality in patients with AIDS. The purpose of this study was to investigate the incidence of CMV disease in a well-defined population of AIDS patients with a high rate of autopsy. No such study has previously been published from Scandinavia. A total of 248 patients who developed clinical AIDS in Oslo during the period I January, 1983 to 31 December, 1995 were included. Autopsy was performed in 152 of 213 deaths (71.3%). CMV disease was diagnosed in 95 patients. In the autopsy group, 73 patients (48%) had CMV disease, and in 52 of these patients CMV disease was first detected at autopsy. Retinitis was the most frequent manifestation, followed by adrenalitis, pneumonitis, encephalitis and gastrointestinal disease. No intravenous drug users (IVDUs) were diagnosed alive with CMV disease. All patients diagnosed with CMV disease before death had evidence of CMV disease at autopsy despite anti-CMV treatment. CMV disease was associated with increased risk of death. We conclude that CMV disease was frequent in patients with AIDS during the study period, was associated with increased mortality and was often diagnosed too late for the administration of appropriate therapy.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 42 条
[1]  
AFESSA B, 1992, J ACQ IMMUN DEF SYND, V5, P132
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[4]   Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy [J].
Brodt, HR ;
Kamps, BS ;
Gute, P ;
Knupp, B ;
Staszewski, S ;
Helm, EB .
AIDS, 1997, 11 (14) :1731-1738
[5]   THE PREDICTIVE VALUE OF CYTOMEGALOVIRUS RETINITIS FOR CYTOMEGALOVIRUS ENCEPHALITIS IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BYLSMA, SS ;
ACHIM, CL ;
WILEY, CA ;
GONZALEZ, C ;
KUPPERMANN, BD ;
BERRY, C ;
FREEMAN, WR .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (01) :89-95
[6]   Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy [J].
Casado, JL ;
Arrizabalaga, J ;
Montes, M ;
Martí-Belda, P ;
Tural, C ;
Pinilla, J ;
Gutierrez, C ;
Portu, J ;
Schuurman, R ;
Aguirrebengoa, K .
AIDS, 1999, 13 (12) :1497-1502
[7]   Impact of opportunistic disease on survival in patients with HIV infection [J].
Chaisson, RE ;
Gallant, JE ;
Keruly, JC ;
Moore, RD .
AIDS, 1998, 12 (01) :29-33
[8]   Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test [J].
Dodt, KK ;
Jacobsen, PH ;
Hofmann, B ;
Meyer, C ;
Kolmos, HJ ;
Skinhoj, P ;
Norrild, B ;
Mathiesen, L .
AIDS, 1997, 11 (03) :F21-F28
[9]   CLINICOPATHOLOGICAL STUDY OF CYTOMEGALOVIRUS (CMV) IN AIDS AUTOPSIES - UNDER-RECOGNITION OF CMV PNEUMONITIS AND CMV ADRENALITIS [J].
DORE, GJ ;
MARRIOTT, DJ ;
DUFLOU, JA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (05) :503-506
[10]   ROLE OF CD8+ IN LATE OPPORTUNISTIC INFECTIONS OF PATIENTS WITH AIDS [J].
FIALA, M ;
KERMANI, V ;
GORNBEIN, J .
RESEARCH IN IMMUNOLOGY, 1992, 143 (09) :903-907